FSA Investment Group LLC Makes New $205,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

FSA Investment Group LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 392 shares of the healthcare conglomerate’s stock, valued at approximately $205,000. UnitedHealth Group makes up approximately 0.2% of FSA Investment Group LLC’s investment portfolio, making the stock its 23rd biggest position.

A number of other large investors have also added to or reduced their stakes in the company. Johnson & White Wealth Management LLC raised its holdings in UnitedHealth Group by 1.5% in the first quarter. Johnson & White Wealth Management LLC now owns 1,798 shares of the healthcare conglomerate’s stock worth $942,000 after purchasing an additional 26 shares in the last quarter. Secure Asset Management LLC increased its holdings in shares of UnitedHealth Group by 30.9% during the first quarter. Secure Asset Management LLC now owns 6,098 shares of the healthcare conglomerate’s stock valued at $3,194,000 after acquiring an additional 1,439 shares in the last quarter. Park Edge Advisors LLC increased its holdings in shares of UnitedHealth Group by 21.8% during the first quarter. Park Edge Advisors LLC now owns 1,016 shares of the healthcare conglomerate’s stock valued at $532,000 after acquiring an additional 182 shares in the last quarter. Long Run Wealth Advisors LLC acquired a new position in shares of UnitedHealth Group during the first quarter valued at about $216,000. Finally, Wealth Alliance Advisory Group LLC increased its holdings in shares of UnitedHealth Group by 1.5% during the first quarter. Wealth Alliance Advisory Group LLC now owns 4,731 shares of the healthcare conglomerate’s stock valued at $2,478,000 after acquiring an additional 70 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 0.3%

Shares of NYSE:UNH opened at $300.37 on Thursday. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The firm has a market capitalization of $272.48 billion, a price-to-earnings ratio of 19.38, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business’s 50 day moving average price is $418.00 and its 200-day moving average price is $488.12.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the business earned $6.91 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. TD Securities restated a “hold” rating and set a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Erste Group Bank downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Oppenheimer cut their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a report on Wednesday, May 14th. Bank of America downgraded shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and cut their price target for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Finally, Hsbc Global Res downgraded shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $428.43.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Kristen Gil bought 3,700 shares of the business’s stock in a transaction on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares of the company’s stock, valued at $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Stephen J. Hemsley bought 86,700 shares of the business’s stock in a transaction on Friday, May 16th. The stock was bought at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.